Long-term follow up of patients who were positive for peritoneal lavage cytology: Final report from the CCOG0301 study

Gastric Cancer

Volumn 15, Issue 3, 2012, Pages 335-337

  Kodera, Yasuhiro ^a   Ito, Seiji ^b   Mochizuki, Yoshinari ^c   Ohashi, Norifumi ^a   Tanaka, Chie ^a   Kobayashi, Daisuke ^a   Kojima, Hiroshi ^b   Matsui, Takanori ^b   Kondo, Ken ^d   Fujiwara, Michitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Komaki Municipal Hospital   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

Cytologic examination; Gastric cancer; Peritoneal carcinomatosis; S 1

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ARTICLE; CLINICAL ARTICLE; CYTOLOGY; FOLLOW UP; GASTRECTOMY; HUMAN; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERITONEAL LAVAGE CYTOLOGY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG COMBINATIONS; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; OXONIC ACID; PERITONEAL CAVITY; PERITONEAL LAVAGE; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 84865438489     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0156-3     Document Type: Article

References (10)

1. Japanese Gastric Cancer Association. Gastric cancer treatment guidelines. 3rd ed. Kanehara: Shuppan (in Japanese); 2010.
2. Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534-9.
3. Koga R, Yamamoto J, Ohyama S, Saiura A, Seki M, Seto Y, et al. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol. 2007;37:836-42.
4. Kodera Y, Ito S, Mochizuki Y, Kondo K, Koshikoawa K, Suzuki N, et al. A phase II study of radical surgery followed by post-operative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol. 2009;35:1158-63.
5. Leake P-A, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, et al. A systemic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Can-cer. 2012 (in press).
6. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma: 2nd English edition. Gastric Cancer. 1998;1:10-24.
7. Okabe H, Sakai Y. Gastrectomy for patients with positive peri-toneal cytology: comments on the article "Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of291 patients". Ann Surg Oncol. 2011;18:S211-4.
8. Kodera Y, Yamamura Y, Shimizu T, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol. 1999;72:60-4.
9. Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17:3173-80.
10. Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus sur-gery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387-93.